Ligand Pharmaceuticals Incorporated
USD314.04
+10.45 (+3.44%)
CEO
Todd C. Davis
IPO Date
1992-11-18
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$303.60
Prev. Close
$303.59
Day Low
$297.41
Day High
$314.75
52W Low
$111.72
52W High
$314.80
Market Cap
$6.29B
Volume
0.46M
| 2,145 |
| $254.00 |
| 18 Jun 2026 | Sabba Stephen L | director | M-Exempt | Disposed | 2,145 | $66.13 |
| 15 Jun 2026 | Haas Jason | director | M-Exempt | Acquired | 3,000 | $51.56 |
| 15 Jun 2026 | Haas Jason | director | M-Exempt | Acquired | 1,000 | $51.56 |
| 15 Jun 2026 | Haas Jason | director | S-Sale | Disposed | 3,000 | $255.01 |
| 15 Jun 2026 | Haas Jason | director | S-Sale | Disposed | 3,461 | $256.08 |
| 15 Jun 2026 | Haas Jason | director | M-Exempt | Disposed | 3,000 | $51.56 |
| 15 Jun 2026 | Haas Jason | director | M-Exempt | Disposed | 1,000 | $51.56 |
| 12 Jun 2026 | Aryeh Jason | director | A-Award | Acquired | 836 | $0.00 |
| $1,001 - $15,000 |
| 13 Feb 2026 | Gilbert Cisneros | Gilbert Cisneros | Purchase | $1,001 - $15,000 |
| 13 Feb 2026 | Gilbert Cisneros | Gilbert Cisneros | Purchase | $1,001 - $15,000 |
| 13 Feb 2026 | Gilbert Cisneros | Gilbert Cisneros | Purchase | $1,001 - $15,000 |
| 13 Feb 2026 | Gilbert Cisneros | Gilbert Cisneros | Purchase | $1,001 - $15,000 |
| 13 Feb 2026 | Gilbert Cisneros | Gilbert Cisneros | Purchase | $1,001 - $15,000 |
| 13 Feb 2026 | Gilbert Cisneros | Gilbert Cisneros | Purchase | $1,001 - $15,000 |
| 3 Dec 2020 | Katherine M. Clark | Katherine M. Clark | Sale (Full) | $1,001 - $15,000 |